Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · Real-Time Price · USD
4.330
0.00 (0.00%)
Nov 21, 2024, 1:36 PM EST - Market open
Lumos Pharma Revenue
Lumos Pharma had revenue of $726.00K in the quarter ending September 30, 2024, with 10,271.43% growth. This brings the company's revenue in the last twelve months to $2.21M, up 26.94% year-over-year. In the year 2023, Lumos Pharma had annual revenue of $2.05M with 34.67% growth.
Revenue (ttm)
$2.21M
Revenue Growth
+26.94%
P/S Ratio
15.98
Revenue / Employee
$66,818
Employees
33
Market Cap
37.45M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Outset Medical | 114.73M |
BioLineRx | 17.05M |
Verrica Pharmaceuticals | 9.21M |
Beyond Air | 2.34M |
Lexaria Bioscience | 411.02K |
Incannex Healthcare | 86.00K |
LUMO News
- 4 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc. - PRNewsWire
- 4 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of Shareholders - PRNewsWire
- 2 months ago - Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024 - GlobeNewsWire
- 3 months ago - Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - GlobeNewsWire
- 4 months ago - Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - GlobeNewsWire
- 6 months ago - Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 - GlobeNewsWire